In contrast, ST3GAL1 modulates immune evasion in prostate cancer by synthesizing sialoglycans that interact with Siglec-7 and Siglec-9 receptors on immune cells [65]. The gene discussed is ST3GAL1; the disease is prostate carcinoma.